Pacira Pharmaceuticals (PCRX) PT Raised to $61 at Northland Capital Markets
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $23.00 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Northland Capital Markets analyst Tim Chiang raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $61.00 (from $57.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- GO Residential REIT (GO-U:CN) PT Lowered to $12.50 at RBC Capital
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
